These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7118254)

  • 1. Cell-mediated cytotoxicity against rat fibroblasts induced by Actinomyces viscosus.
    Gaegauf-Zollinger R; Burckhardt JJ; Gmür R; Guggenheim B
    Infect Immun; 1982 Aug; 37(2):710-9. PubMed ID: 7118254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rat memory T lymphocytes. II. Differences in macrophage-dependent activation shown by Actinomyces viscosus antigens and by mitogens, using silica in vitro.
    Burckhardt JJ
    Scand J Immunol; 1979; 10(3):229-35. PubMed ID: 230582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rat memory T lymphocytes: in vitro proliferation induced by antigens of Actinomyces viscosus.
    Burckhardt JJ
    Scand J Immunol; 1978; 7(2):167-72. PubMed ID: 306665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The absence of binding sites for antigens of Actinomyces viscosus on rat fibroblasts.
    Hefti A; Guggenheim B
    J Periodontal Res; 1981 Jan; 16(1):20-5. PubMed ID: 6165814
    [No Abstract]   [Full Text] [Related]  

  • 5. The mitogenicity for murine splenocytes of specific surface components of the oral periodontopathic bacterium, Actinomyces viscosus.
    Halfpap LM; Brown DA; Clagett JA; Birdsell DC
    Arch Oral Biol; 1985; 30(9):661-6. PubMed ID: 3865642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New cellular and extracellular amphipathic antigen from Actinomyces viscosus NY1.
    Wicken AJ; Broady KW; Evans JD; Knox KW
    Infect Immun; 1978 Nov; 22(2):615-6. PubMed ID: 730376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitogenic activity of Actinomyces viscosus. I. Effects on murine B and T lymphocytes, and partial characterization.
    Engel D; Clagett J; Page R; Williams B
    J Immunol; 1977 Apr; 118(4):1466-71. PubMed ID: 66295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of topically applied anti-Actinomyces viscosus Ny1 R2 antibodies in rat gingivitis].
    Kijima S
    Nihon Shishubyo Gakkai Kaishi; 1986 Dec; 28(4):1044-53. PubMed ID: 3470400
    [No Abstract]   [Full Text] [Related]  

  • 9. Cell-mediated and humoral immune responses of guinea-pigs to the oral bacterium Actinomyces viscosus.
    Doroszczak N; Chen P
    Arch Oral Biol; 1982; 27(12):993-8. PubMed ID: 6963887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response to keyhole limpet hemocyanin and oral Actinomyces viscosus antigens in Macaca arctoides.
    Reed MJ; Borkow I; Staple PH
    J Periodontol; 1981 Mar; 52(3):111-8. PubMed ID: 6939831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in lymphoproliferative responses to the bacterium Actinomyces viscosus in various mammalian species.
    Chen P; Doroszczak N
    Arch Oral Biol; 1982; 27(4):319-24. PubMed ID: 6953950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro stimulation of immunoglobulin production from human peripheral blood lymphocytes by a soluble preparation of Actinomyces viscosus.
    Mangan DF; Lopatin DE
    Infect Immun; 1981 Jan; 31(1):236-44. PubMed ID: 6971261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are Actinomyces viscosus antigens B cell mitogens?
    Burckhardt JJ; Guggenheim B; Hefti A
    J Immunol; 1977 Apr; 118(4):1460-5. PubMed ID: 300408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alveolar bone loss in rats after immunization with Actinomyces viscosus.
    Burckhardt JJ; Gaegauf-Zollinger R; Schmid R; Guggenheim B
    Infect Immun; 1981 Mar; 31(3):971-7. PubMed ID: 7228410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of suppressor cells following mucosal presentation of Actinomyces viscosus in mice.
    Sosroseno W; Bird PS; Gemmell E; Seymour GJ
    Oral Microbiol Immunol; 2003 Oct; 18(5):318-22. PubMed ID: 12930525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of macrophages in the lymphocyte response to Actinomyces viscosus.
    McCarron RM; Fitzgerald JE; Birdsell DC
    Infect Immun; 1982 Nov; 38(2):623-30. PubMed ID: 6982867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptidoglycan from the potentially pathogenic oral bacterium Actinomyces viscosus is a B-cell mitogen.
    Baker JJ
    Arch Oral Biol; 1985; 30(3):291-4. PubMed ID: 3873234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple low-dose streptozotocin-induced diabetes in the mouse. Evidence for stimulation of a cytotoxic cellular immune response against an insulin-producing beta cell line.
    McEvoy RC; Andersson J; Sandler S; Hellerström C
    J Clin Invest; 1984 Sep; 74(3):715-22. PubMed ID: 6088584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic control of serum antibody responses of inbred mice to type 1 and type 2 fimbriae from Actinomyces viscosus T14V.
    Haber J; Grinnell CM; Beem JE; Clark WB
    Infect Immun; 1991 Jul; 59(7):2364-9. PubMed ID: 1675628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyclonal induction of IgG antibody forming cells by stimulation with Actinomyces viscosus T14V.
    Harada Y; Ito H; Miki Y; Ebisu S; Okada H
    J Periodontal Res; 1988 Mar; 23(2):122-6. PubMed ID: 2967364
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.